Alfuzosin hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

Company

DUNS: 181620514

Effective Date

March 25, 2022

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Alfuzosin(10 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NDC Product Code

29300-155

Application Number

ANDA203192

Marketing Category

ANDA (C73584)

Route of Administration

ORAL

Effective Date

March 25, 2022

Ingredients

Code: 75046A1XTNClass: ACTIBQuantity: 10 mg in 1 1

HYPROMELLOSE 2208 (100000 MPA.S)Inactive

Code: VM7F0B23ZIClass: IACT

HYPROMELLOSE 2910 (5 MPA.S)Inactive

Code: R75537T0T4Class: IACT

MAGNESIUM STEARATEInactive

Code: 70097M6I30Class: IACT

POVIDONE K30Inactive

Code: U725QWY32XClass: IACT

LACTOSE MONOHYDRATEInactive

Code: EWQ57Q8I5XClass: IACT

SILICON DIOXIDEInactive

Code: ETJ7Z6XBU4Class: IACT